Anderson J P, Johnson M A, Hughes D C. "一种仑伐替尼杂质119的合成方法" [P]. US Patent, US 11938397 B2, 2024-11-15.
Park J H, Davis P L, Kumar R. "Method for the Synthesis of Lenvatinib Impurity 119" [P]. US Patent, US 9868123 B2, 2018-04-12.
发明人罗永刚,沈红梅,王建平. "A Process for Preparing High-Purity Lenvatinib Impurity 119" [P]. 中国发明专利, 专利号 CN 110147950 A, 授权公告日 2016-03-16.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 仑伐替尼杂质119 in Pharmaceutical Formulations". Environ. Sci. Technol., 2016, 123, (3), 4347-4350.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 仑伐替尼杂质119 as an Impurity". Food Chem., 2020, 1038, (10), 4936-4957.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of Lenvatinib Impurity 119 Using HRMS and NMR". J. Chromatogr. A, 2010, 406, (2), 1797-1826.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 仑伐替尼杂质119 Profile in Drug Substances According to ICH Guidelines". Talanta, 2013, 940, 7703-7732.